Hologic Announces Financial Results for Second Quarter of Fiscal 2016

Go back to Hologic Announces Financial Results for Second Quarter of Fiscal 2016

Needham & Company Downgrades Hologic (HOLX) to Hold

April 28, 2016 7:36 AM EDT

Needham & Company downgraded Hologic (NASDAQ: HOLX) from Buy to Hold.

Analyst Mike Matson commented, "HOLX's F2Q16 revenue and EPS beat consensus and management raised its FY16 guidance. HOLX's revenue growth slowed to 6% CC in F2Q16 from 8% CC in F1Q16. Positives... More

Hologic (HOLX) Tops Q2 EPS by 1c; Bumps Outlook

April 27, 2016 4:14 PM EDT

Hologic (NASDAQ: HOLX) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $693.3 million versus the consensus estimate of $687.41 million.

"We posted another good quarter, highlighted by 14.6% growth in non-GAAP EPS," said Steve MacMillan, the Company's... More